计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| N302245-1g |
1g |
期货 ![]() |
| |
| N302245-5g |
5g |
期货 ![]() |
| |
| N302245-25g |
25g |
期货 ![]() |
| |
| N302245-100g |
100g |
期货 ![]() |
|
| 英文别名 | Cronoformin | Prestwick2_000179 | Debinyl | HMS3604G03 | Dibein | Fenfoduron | MFCD00242966 | NCGC00016543-02 | MLS006011899 | 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine | 114-86-3 (FREE BASE) | 1-carbamimidamido-N-(2-phenylethyl)methanimidamide | |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | N-Phenethylbiguanide |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 激活剂 |
| 产品介绍 |
它可于溶于浓硫酸、二甲基甲酰胺、二甲基亚砜、n-甲基吡咯烷酮和六甲基磷酰胺等。 |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine |
| INCHI | 1S/C10H15N5/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H6,11,12,13,14,15) |
| InChi Key | ICFJFFQQTFMIBG-UHFFFAOYSA-N |
| Smiles | C1=CC=C(C=C1)CCN=C(N)N=C(N)N |
| Isomeric SMILES | C1=CC=C(C=C1)CCN=C(N)N=C(N)N |
| 分子量 | 205.26 |
| Reaxy-Rn | 22781826 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=22781826&ln= |
| 折光率 | 1.6380 (estimate) |
|---|---|
| 沸点 | 333.94°c (rough estimate) |
| 熔点 | 176.5 °C |
| 分子量 | 205.260 g/mol |
| XLogP3 | -0.800 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 1 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 205.133 Da |
| 单同位素质量Monoisotopic Mass | 205.133 Da |
| 拓扑极表面积Topological Polar Surface Area | 103.000 Ų |
| 重原子数Heavy Atom Count | 15 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 236.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Zixian He, Zhiwei Liu, Haihuan Xie, Pengjie Luo, Xiangmei Li. (2023) An Ultrasensitive Lateral Flow Immunoassay Based on Metal-Organic Framework-Decorated Polydopamine for Multiple Sulfonylureas Adulteration in Functional Foods. Foods, 12 (3): (539). [PMID:36766067] [10.3390/foods12030539] |
| 2. Haihuan Xie, Yingying Li, Jin Wang, Yi Lei, Anastasios Koidis, Xiangmei Li, Xing Shen, Zhenlin Xu, Hongtao Lei. (2022) Broad-specific immunochromatography for simultaneous detection of various sulfonylureas in adulterated multi-herbal tea. FOOD CHEMISTRY, 370 (131055). [PMID:34536782] [10.1016/j.foodchem.2021.131055] |
| 3. Lingli Huang, Di Xiao, Tianyu Wu, Xin Hu, Jun Deng, Xinjian Yan, Jingtao Wu, Simeng Xu, Xiaoping Yang, Gaofeng Li. (2021) Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways. American Journal of Translational Research, 13 (7): ( 7508–7523). [PMID:34377232] |
| 4. Tianyu Wu, Sichun Zhou, Mei Qin, Jing Tang, Xinjian Yan, Lingli Huang, Meiyuan Huang, Jun Deng, Di Xiao, Xin Hu, Jingtao Wu, Xiaoping Yang, Gaofeng Li. (2021) Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria. FEBS Open Bio, 11 (5): (1440-1451). [PMID:33742560] [10.1002/2211-5463.13152] |
| 5. Peng Mei, Deng Jun, Zhou Sichun, Xiao Di, Long Jiahui, Zhang Nan, He Caimei, Mo Miao, Yang Xiaoping. (2019) Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth. Frontiers in Pharmacology, 10 (1159). [PMID:31649535] [10.3389/fphar.2019.01159] |
| 6. Huang Yanjun, Zhou Sichun, He Caimei, Deng Jun, Tao Ting, Su Qiongli, Darko Kwame Oteng, Peng Mei, Yang Xiaoping. (2018) Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways. Cancer Communications, 38 (1): (1-14). [PMID:30053908] [10.1186/s40880-018-0319-7] |